BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4718770)

  • 41. [Value of amniotic fluid-serum HPL quotients for the monitoring of pregnancies at risk].
    During R; Kunkel S
    Zentralbl Gynakol; 1978; 100(9):589-93. PubMed ID: 676576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Radioimmunoassay of somatotropin (STH) and placental lactogen (HPL) during normal pregnancy].
    Janisch H; Spona J
    Wien Klin Wochenschr; 1973 Mar; 85(11):167-9. PubMed ID: 4691816
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of chorionic somatomammotrophin levels under various conditions of a pregnant woman].
    Proto M; Guidobono F; Pecile A
    Minerva Ginecol; 1974 Nov; 26(11):681-4. PubMed ID: 4444809
    [No Abstract]   [Full Text] [Related]  

  • 44. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnostic assessment of normal and risk pregnancies. 1. Comparison of two radioimmunological methods for the determination of human placental lactogen (author's transl)].
    Musch K; Wolf AS; Lauritzen C
    Geburtshilfe Frauenheilkd; 1978 May; 38(5):365-70. PubMed ID: 648860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinico-statistical correlations between HPL and neonatal weight and Apgar index].
    Basile F; Weisz G; Bini P; Giaretto G
    Minerva Ginecol; 1978 Dec; 30(12):1089-96. PubMed ID: 105330
    [No Abstract]   [Full Text] [Related]  

  • 47. Human placental lactogen in high-risk pregnancy.
    Spellacy WN
    Clin Obstet Gynecol; 1973 Mar; 16(1):298-312. PubMed ID: 4196839
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical indications for targeted long-term monitoring of risk pregnancy using radioimmunologic HPL determination].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6211054
    [No Abstract]   [Full Text] [Related]  

  • 49. Peptide hormones in assessing fetal status.
    Spellacy WN
    Clin Perinatol; 1974 Mar; 1(1):65-72. PubMed ID: 4470050
    [No Abstract]   [Full Text] [Related]  

  • 50. [Radioimmunologic determination of estriol, HPL, and alpha fetoprotein in maternal serum and their values in pregnancies at risk (proceedings)].
    Arnold P; Rauskolb R; Jovanović V; Bleyl H
    Arch Gynakol; 1977 Jul; 224(1-4):123-4. PubMed ID: 74991
    [No Abstract]   [Full Text] [Related]  

  • 51. [Human Placental Lactogen (HPL) in the diagnosis of risk pregnancy].
    Stiglmayer R
    Jugosl Ginekol Opstet; 1976; 16(1):53-8. PubMed ID: 966806
    [No Abstract]   [Full Text] [Related]  

  • 52. Amniotic, urinary and serum hormones in fetal diagnosis.
    Farquhar JW
    Can Med Assoc J; 1971 Jul; 105(2):174-6 passim. PubMed ID: 4933694
    [No Abstract]   [Full Text] [Related]  

  • 53. [Urinary estriol, serum HPL and intrauterine retardation of fetal growth].
    Iarŭkov A
    Akush Ginekol (Sofiia); 1987; 26(1):20-4. PubMed ID: 3592103
    [No Abstract]   [Full Text] [Related]  

  • 54. Elevated levels of b-human chorionic gonadotropin and human placental lactogen between 11-13 weeks' gestation and subsequent pregnancy complications in Omani women.
    Krolikowski A; Al Busaidi F; Al Wahaibi A
    Saudi Med J; 2004 Mar; 25(3):382-4. PubMed ID: 15048184
    [No Abstract]   [Full Text] [Related]  

  • 55. Radioimmunoassay of serum SP 1 and HPL in normal and abnormal pregnancies.
    Pluta M; Hardt W; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Arch Gynecol; 1979; 227(4):327-36. PubMed ID: 316310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum concentration of human placental lactogenic hormone (HPL) in pregnancy complications.
    Seppälä M; Ruoslahti E
    Acta Obstet Gynecol Scand; 1970; 49(2):143-7. PubMed ID: 4997062
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
    Kyank HR
    Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma levels of pregnancy-specific beta 1-glycoprotein in complicated pregnancies.
    Towler CM; Horne CH; Jandial V; Campbell DM; MacGillivray I
    Br J Obstet Gynaecol; 1977 Apr; 84(4):258-63. PubMed ID: 870010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human placental lactogen and pregnancy-associated plasma protein A in first trimester and subsequent fetal growth.
    Pedersen JF; Sørensen S; Ruge S
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):505-8. PubMed ID: 7542426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.